Long noncoding RNAs and their contribution to 22q11.2 deletion syndrome

长非编码 RNA 及其对 22q11.2 缺失综合征的贡献

基本信息

项目摘要

 DESCRIPTION (provided by applicant): 22q11.2 deletion syndrome is one of the most common microdeletion syndromes in humans. The deletions result in a haploinsufficiency of over 60 genes, 4 microRNAs, and a group of uncharacterized long noncoding RNAs. Individuals with 22q11.2 deletion syndrome can present with many clinical complications including three that are commonly linked, thymic hypoplasia, hypocalcemia related to the parathyroid hypoplasia, and cardiac anomalies. Additional clinical manifestations include growth delay, facial dysmorphology, learning disorders, and/or schizophrenia. Those patients with a hypoplastic thymus have reduced thymopoiesis. This causes a peripheral T cell lymphopenia, with fewer effector and regulatory T cells present in these individuals. Insufficient numbers of such T cells increases the severity and duration of infections and autoimmune disorders. The thymus hypoplasia, the hypoparathyroidism, and defects in the outflow tracts of the heart, result from impaired tissue specification of the pharyngeal apparatus. We characterized human thymic tissues from normal and 22q11.2 deletion syndrome patients with a combination of histology, immunohistochemistry, flow cytometry, microRNA (miR) arrays, RT-PCR, and RNA sequencing. Preliminary findings reveal a deficiency of miR-205 and the surrounding long noncoding RNA (lncRNA, MIR205HG) in the hypoplastic tissues from a subset of 22q11.2 deletion syndrome patients. We have generated conditional knockout mice for the murine homolog of the lncRNA and have miR-205 conditional knockout lines. Preliminary findings indicate that miR-205 is required for T cell output during normal and stress situations. A complete deficiency of lncRNA results in a growth delay in the mice. By using diverse conditional knockout mice, and comparing the phenotypes in these mice to those reported for chromosome 22q11.2 deletion syndrome, we will determine how the novel RNA species result in poor T cell output and developmental delays. The studies will include a comparative analysis of human thymii from normal and 22q11.2 deletion syndrome patients.
 描述(由申请人提供):22q11.2缺失综合征是人类最常见的微缺失综合征之一。这些缺失导致 60 多个基因、4 个 microRNA 和一组未表征的长非编码 RNA 的单倍体不足。患有 22q11.2 缺失综合征的个体可能会出现许多临床并发症,包括三种常见的并发症:胸腺发育不全、与甲状旁腺发育不全相关的低钙血症和心脏异常。其他临床表现包括生长迟缓、面部畸形、学习障碍和/或精神分裂症。那些胸腺发育不全的患者胸腺生成能力降低。这会导致外周 T 细胞淋巴细胞减少,这些个体中存在较少的效应 T 细胞和调节性 T 细胞。此类 T 细胞数量不足会增加感染和自身免疫性疾病的严重程度和持续时间。胸腺发育不全、甲状旁腺功能减退和心脏流出道缺陷是由咽部组织规格受损造成的。我们结合组织学、免疫组织化学、流式细胞术、microRNA (miR) 阵列、RT-PCR 和 RNA 测序,对正常和 22q11.2 缺失综合征患者的人类胸腺组织进行了表征。初步研究结果显示,22q11.2 缺失综合征患者的发育不全组织中存在 miR-205 和周围的长非编码 RNA(lncRNA、MIR205HG)缺陷。我们已经生成了 lncRNA 小鼠同源物的条件敲除小鼠,并拥有 miR-205 条件敲除系。初步研究结果表明,在正常和应激情况下,T 细胞输出需要 miR-205。 lncRNA完全缺乏会导致小鼠生长迟缓。通过使用不同的条件敲除小鼠,并将这些小鼠的表型与报道的染色体 22q11.2 缺失综合征的表型进行比较,我们将确定新型 RNA 物种如何导致 T 细胞输出不良和发育迟缓。这些研究将包括对正常人和 22q11.2 缺失综合征患者的人类胸腺进行比较分析。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NICOLAI Stanislas Cyrille VAN OERS其他文献

NICOLAI Stanislas Cyrille VAN OERS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NICOLAI Stanislas Cyrille VAN OERS', 18)}}的其他基金

Coding and Noncoding RNA Contributions to 22q11.2 Deletion Syndrome
编码和非编码 RNA 对 22q11.2 缺失综合征的贡献
  • 批准号:
    10442758
  • 财政年份:
    2015
  • 资助金额:
    $ 43.15万
  • 项目类别:
Coding and Noncoding RNA Contributions to 22q11.2 Deletion Syndrome
编码和非编码 RNA 对 22q11.2 缺失综合征的贡献
  • 批准号:
    10206036
  • 财政年份:
    2015
  • 资助金额:
    $ 43.15万
  • 项目类别:
Coding and Noncoding RNA Contributions to 22q11.2 Deletion Syndrome
编码和非编码 RNA 对 22q11.2 缺失综合征的贡献
  • 批准号:
    10641854
  • 财政年份:
    2015
  • 资助金额:
    $ 43.15万
  • 项目类别:
MicroRNA Profiling of Pediatric Immunodeficiency Patients
儿童免疫缺陷患者的 MicroRNA 分析
  • 批准号:
    7707193
  • 财政年份:
    2009
  • 资助金额:
    $ 43.15万
  • 项目类别:
MicroRNA Profiling of Pediatric Immunodeficiency Patients
儿童免疫缺陷患者的 MicroRNA 分析
  • 批准号:
    7934643
  • 财政年份:
    2009
  • 资助金额:
    $ 43.15万
  • 项目类别:
CD3 e functions in T cells
CD3 e 在 T 细胞中的功能
  • 批准号:
    7897161
  • 财政年份:
    2009
  • 资助金额:
    $ 43.15万
  • 项目类别:
PTPN4 Functions in Lymphocytes
PTPN4 在淋巴细胞中的功能
  • 批准号:
    7530435
  • 财政年份:
    2008
  • 资助金额:
    $ 43.15万
  • 项目类别:
PTPN4 Functions in Lymphocytes
PTPN4 在淋巴细胞中的功能
  • 批准号:
    7648069
  • 财政年份:
    2008
  • 资助金额:
    $ 43.15万
  • 项目类别:
CD3 e functions in T cells
CD3 e 在 T 细胞中的功能
  • 批准号:
    7685132
  • 财政年份:
    2008
  • 资助金额:
    $ 43.15万
  • 项目类别:
T Cell Receptor Signaling by Phosphorylated Forms of TCR
TCR 磷酸化形式的 T 细胞受体信号传导
  • 批准号:
    6906601
  • 财政年份:
    1999
  • 资助金额:
    $ 43.15万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 43.15万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.15万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 43.15万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.15万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 43.15万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 43.15万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.15万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 43.15万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 43.15万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.15万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了